Combined genetic screening for pregnancy and cancer risk
Part of Cancer, Genetic & congenital clinical trials.
This trial offers a combined genetic test for both common inherited conditions and hereditary cancer risks to pregnant women or those planning pregnancy. It aims to see if adding cancer screening to routine pregnancy testing is helpful.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old
- You are pregnant or planning to become pregnant
- You are getting care at a Weill Cornell Medicine clinic
- You have chosen to have carrier screening as part of your pregnancy care
- You have not already had a comprehensive genetic test for hereditary cancer
- You do not have a blood cancer or a condition that can turn into blood cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a way to help people with inherited cancer gene mutations manage their health, especially if they live in rural areas. You join if you found out about the mutation more than a year ago.
This study combines routine obstetrical carrier screening with hereditary cancer risk screening in one blood draw. It aims to see if offering both tests together is feasible and helpful for patients receiving OB care.
This study tests a new online way to offer genetic testing and counseling for people concerned about hereditary cancer. It aims to make it easier and faster to access these services from home.
This study looks at DNA (genetic information) from people and families who may have an inherited risk for cancer. It aims to find new genetic markers that can help explain cancer risk and guide future care.
This trial tests whether a special program can help people with cancer-related genetic changes get the right screening and prevention care. It aims to improve how doctors manage your health based on your genes.
This study offers free genetic testing to women, trans men, and non-binary people (with female reproductive organs) who have not had previous testing for certain cancer-related genes. It aims to find people at higher risk for cancer so they can take steps to prevent it or catch it early.
Hear when a new Hereditary Cancer Syndromes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.